Your browser doesn't support javascript.
loading
Explore the optimal timing for administering the second dose of the varicella vaccine in China.
Sun, Xiang; Wang, Yong; Zhang, Lei; Liu, Yuanbao; Xu, Ling-Xiao; Chen, Qiang; Sun, Hui; Wang, Fangfang; Wang, Zhiguo; Wang, Wen.
Afiliación
  • Sun X; Department of Expanded Program on Immunization, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, Jiangsu, China.
  • Wang Y; Scientific Research Department, Northern Jiangsu People's Hospital, Yangzhou, Jiangsu, China.
  • Zhang L; Department of Expanded Program on Immunization, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, Jiangsu, China.
  • Liu Y; Department of Expanded Program on Immunization, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, Jiangsu, China.
  • Xu LX; Department of Rheumatology and Immunology, The Affiliated Suqian First People's Hospital of Nanjing Medical University, Suqian, China.
  • Chen Q; Department of Expanded Program on Immunization, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, Jiangsu, China.
  • Sun H; Medical Department, The Affiliated Hospital of Nanjing University of Traditional Chinese Medicine, Nanjing, China.
  • Wang F; Department of Hematology, Yangzhou University Clinical Medical College, Yangzhou, Jiangsu, China.
  • Wang Z; Department of Expanded Program on Immunization, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, Jiangsu, China.
  • Wang W; Department of Rheumatology and Immunology, The Affiliated Suqian First People's Hospital of Nanjing Medical University, Suqian, China.
J Med Virol ; 95(9): e29119, 2023 09.
Article en En | MEDLINE | ID: mdl-37737678

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Antígenos de Grupos Sanguíneos / Vacunas Virales / Varicela Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans / Infant País/Región como asunto: Asia Idioma: En Revista: J Med Virol Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Antígenos de Grupos Sanguíneos / Vacunas Virales / Varicela Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans / Infant País/Región como asunto: Asia Idioma: En Revista: J Med Virol Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos